Skip to content

Study · Systematic review · 2026

3 results

Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.

Toledo RG, Winkelman WD, Reyes-Gonzalez D, Bergeron S, Fladger A, Hacker MR, Anand M

Journal of minimally invasive gynecology19 Jun 2025Cited by 2 (Europe PMC)

PMID40543759 (opens in a new tab)DOI10.1016/j.jmig.2025.06.004 (opens in a new tab)PepBankPUB-40543759
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanSystematic reviewEfficacy outcome

    In a meta-analysis in women with sexual desire, arousal or orgasm dysfunction, bremelanotide improved the total Female Sexual Function Index score.

    In plain wordsIn a pooled analysis of women with sexual dysfunction, bremelanotide improved total sexual function scores.

    Peptide
    Bremelanotide (PT-141)
    Outcome
    IncreaseTotal FSFI score
    Study

    n: not reported in source

    Outcome group
    Sexual function · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    bremelanotide improved total FSFI and its desire and arousal subscales.
    1 context sentence
    Summary · context
    To conduct a systematic review and meta-analysis of treatments for female sexual desire, arousal, and orgasmic dysfunction in patients without sexual pain conditions.
  2. 02HumanSystematic reviewEfficacy outcome

    In a meta-analysis in women with sexual desire, arousal or orgasm dysfunction, bremelanotide improved the FSFI desire subscale.

    In plain wordsIn a pooled analysis of women with sexual dysfunction, bremelanotide improved sexual desire scores.

    Peptide
    Bremelanotide (PT-141)
    Outcome
    IncreaseFSFI desire subscale
    Study

    n: not reported in source

    Outcome group
    Sexual function · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    bremelanotide improved total FSFI and its desire and arousal subscales.
    1 context sentence
    Summary · context
    To conduct a systematic review and meta-analysis of treatments for female sexual desire, arousal, and orgasmic dysfunction in patients without sexual pain conditions.
  3. 03HumanSystematic reviewEfficacy outcome

    In a meta-analysis in women with sexual desire, arousal or orgasm dysfunction, bremelanotide improved the FSFI arousal subscale.

    In plain wordsIn a pooled analysis of women with sexual dysfunction, bremelanotide improved sexual arousal scores.

    Peptide
    Bremelanotide (PT-141)
    Outcome
    IncreaseFSFI arousal subscale
    Study

    n: not reported in source

    Outcome group
    Sexual function · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    bremelanotide improved total FSFI and its desire and arousal subscales.
    1 context sentence
    Summary · context
    To conduct a systematic review and meta-analysis of treatments for female sexual desire, arousal, and orgasmic dysfunction in patients without sexual pain conditions.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.